Anaplastic Oligodendroglioma (AO) Completed Phase 1 Trials for Temsirolimus (DB06287)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02238496Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasTreatment